Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
OBJECTIVES: Two 12-week, randomized, double-blind, parallel-group studies were performed to compare the efficacy and safety of once- and twice-daily dosing of fluticasone propionate (FP) in the treatment of mild to moderate asthma, considered to require the equivalent of either 200 or 500 µg of FP d...
Saved in:
Main Authors: | Louis-Philippe Boulet, Robert L Cowie, Roberto Dal Negro, Wade Brett, Milton Gold, Agostinho Marques, William S Thorburn, Nate M Stepner, Reid Bobson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2000/464639 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01) -
A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily PPIs versus Once Daily for Treatment of Gastroesophageal Reflux Disease
by: Hongying Zhang, et al.
Published: (2017-01-01) -
In vitro effects of fluticasone propionate
on IL-13 production by mitogen-stimulated lymphocytes
by: Gabriele Di Lorenzo, et al.
Published: (2002-01-01) -
Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Hilla Mills, et al.
Published: (2022-01-01) -
Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Emergency Medicine International
Published: (2024-01-01)